Clinical features and types of Von Willebrand disease in women with menorrhagia referred to Hematology Clinic of Kermanshah
Abstract
Menorrhagia is the most common symptom that is experienced by women with bleeding disorders. Von Willebrand disease (VWD) is the most common congenital human bleeding disorder that is manifested as a quantitative deficiency in Von Willebrand factor (VWF) or dysfunction of this factor. The frequency of VWD is similar in both men and women. However, VWD is more readily detected in women due to the presence of severe bleeding associated with menstrual cycles and childbirth. The present study was carried out to find the frequency of VWD, its types, and clinical features of the disease among women with menorrhagia who referred to the Hematology Clinic of the Kermanshah University of Medical Sciences. The study comprised 482 women with menorrhagia. After excluding patients with confounding factors, 56 (11.6%) patients were evaluated for inherited bleeding disorders. We detected 31 (55.3%) patients with VWD. Type 3 of VWD was the most frequent subtype (45.2%) followed in frequency by type 2 (32.3%), and type 1 (22.5%). In conclusion, our study indicated that menorrhagia can be the first symptom of VWD. Therefore, rare coagulation disorders should be considered in women with idiopathic menorrhagia, particularly in regions with high rates of consanguinity.
Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health and Social Security. Morbidity statistics from general practice. Third National Study 1981 – 1982. Series MBS No. 1. London: HMSO, 1986.
Bradlow J, Coulter A, Brooks P. Patterns of Referral. Oxford: Health Services Research Unit, 1992.
Rees M. Menorrhagia. BMJ 1987; 294:759 – 762.
Kouides PA, Kadir RA. Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects. J Thromb Haemost. 2007; 5(Suppl 1):175–182.
James AH, Kouides PA, Abdul-Kadir R, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009; 201(1):12.e1–12.e8.
Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. Von Willebrand disease in women with menorrhagia: a systematic review. Br J Obstet Gynaecol. 2004; 111(7):734–740.
Nichols WC, Ginsburg D. Von Willebrand disease. Medicine 1997; 76:1–20.
Frederici AB, Manucci PM. Advances in the genetics and treatment of von Willebrand disease. Curr Opin Pediatr 2002; 14:23 – 33.
Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 1999; 82:1456 – 1461.
Laffan MA, Manning RA. Investigation of haemostasis. In Dacie JV, Lewis SM, eds. Lewis Practical Haematology. 9th ed. Churchill Livingstone; 2001:339-390.
Visudhiphan S. Laboratory Manual of Hemostasis. Bangkok, Thailand: Ruen Kaew; 1992; Harcourt Publishers Limited, London.
Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Throm-bosis and Haemostasis. Thromb Haemost. 1994; 71(4):520-525.
Sadler JE, Budde U, Eikenboom JC, et al. Update on the patho-physiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006; 4(10):2103-2114.
Laffan M, Brown SA, Collins PW, et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organization. Haemophilia. 2004; 10(3):199-217.
Lak M, Peyvandi F, Mannucci PM. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand diseases. Br J Haema tol. 2000; 111(4):1236-1239.
Gupta M, Bhattacharyya M, Choudhry VP, Saxena R. Spectrum of inherited bleeding disorders in Indians. Clin Appl Thromb Hemost. 2005; 11(3):325-330.
Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104:1243–1252.
Fricke W, Kouides P, Kessler C, et al. A multicenter clinical evaluation of the Clot Signature analyzer. J Thromb Haemost. 2004; 2:763–768.
Kouides PA. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertility Sterility. 2005; 84:1345–1350.
Adcock DM. Bleeding disorders associated with menorrhagia. Clin Hemost Rev. 2003; 17(1):1–5.
Dilley A, Drews C, Miller C, Lally C, Austin H, Ramaswamy D, et al. The von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynaecol 2001; 97:630-6.
Vo KT, Grooms L, Klima J, Holland-Hall C, O'Brien SH. Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent hematology clinic. Haemophilia. 2012. doi: 10.1111/hae.12012.c
Borhany M, Shamsi T, Naz A, Farzana T, Ansari S, Nadeem M, Rehman ZU, Sangii Z. Clinical features and types of von Willebrand disease in Karachi. Clin Appl Thromb Hemost. 2011; 17(6):E102-5.
Rodeghiero F, Castaman G, Dini E. Epidemiological Investiga-tion of the Prevalence of von Willebrand’s Disease. Blood 1987; 69(2):454-459.
Nichols WL, Hultin MB, James AH, et al. Von Willebrand dis-ease (VWD): evidence-based diagnosis and management guide-lines, the National Heart, lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008; 14(2):171-232
Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and gen-otype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109(1):112-121.
Files | ||
Issue | Vol 7, No 2 (2013) | |
Section | Articles | |
Keywords | ||
Bleeding disorders Coagulation disorders Menorrhagia Von Willebrand disease |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |